CD8A and infection: In addition, treatment with IL-4c at 2 days interval before MuHV-4-luc infection intranasally at day 4 reduced the levels of light emission reporting infection (Fig. 7c), which was associated with enhanced effector CD8+ T cell responses in the lung after MuHV-4 infection (Fig. 7d, e).